ELSA: Medical grade symptom tracker, telemedicine and real-world evidence tracking app for Endometriosis

赛诺纳有限公司是一家快速发展的英国中小企业，专门从事数字健康。赛诺纳正在解决市场上一个巨大的未得到满足的可持续创新缺口，该缺口可能会支持英国200万患有子宫内膜异位症/子宫内膜异位症样症状的女性。随着新冠肺炎扰乱性健康和生殖健康服务的获得，许多选择性妇科服务已被暂停，这对患有子宫内膜异位症/子宫内膜异位症样症状的女性有长期影响。赛诺纳旨在提供医疗级子宫内膜异位症症状跟踪器、远程医疗和真实世界的证据跟踪应用程序，使女性能够数字化她们的患者体验，减少住院预约的需求。

Syrona Ltd. is a rapidly growing UK SME specialising in digital health.Syrona is solving a substantial unmet sustainable innovation gap in the market that could support 2 million women in the UK with endometriosis/endometriosis-like symptoms. With COVID-19 disrupting access to sexual and reproductive health services, many elective gynaecological services have been suspended, having long-term implications for women with endometriosis/endometriosis-like symptoms.Syrona aims to provide a medical-grade endometriosis symptom tracker, telemedicine and real-world evidence tracking app, which allows women to digitise their patient experience and reduce the need for in-patient appointments.